

765. Eur Arch Otorhinolaryngol. 2018 Jun;275(6):1365-1373. doi:
10.1007/s00405-018-4954-z. Epub 2018 Mar 27.

Highlights from the Second International Symposium on HPV infection in head and
neck cancer.

Wiegand S(1), Wichmann G(2), Golusinski W(3), Leemans CR(4), Klussmann JP(5),
Dietz A(2).

Author information: 
(1)Department of Otolaryngology, Head and Neck Surgery, University of Leipzig,
Liebigstrasse 12, 04103, Leipzig, Germany.
Susanne.wiegand@medizin.uni-leipzig.de.
(2)Department of Otolaryngology, Head and Neck Surgery, University of Leipzig,
Liebigstrasse 12, 04103, Leipzig, Germany.
(3)Department of Head and Neck Surgery, Greater Poland Cancer Centre, Poznan
University of Medical Sciences, Pozna≈Ñ, Poland.
(4)Department of Otolaryngology Head and Neck Surgery, VU University Medical
Center, Amsterdam, The Netherlands.
(5)Department of Otorhinolaryngology, Head and Neck Surgery, University of
Giessen, Giessen, Germany.

The Second International Symposium on HPV Infection in Head and Neck Cancer was
held on 3rd-4th November 2016 in Leipzig, Germany. The meeting brought together
researchers and clinicians to share the latest knowledge on HPV infection in head
and neck cancer and to join active and constructive scientific discussions. This 
report summarizes the major themes discussed during the symposium.

DOI: 10.1007/s00405-018-4954-z 
PMID: 29589141  [Indexed for MEDLINE]
